Learn About Hemosiderosis
- Hemosiderosis
University Of Virginia Physicians Group
Michael Keng is a Hematologist and an Oncologist in Charlottesville, Virginia. Dr. Keng and is rated as an Experienced provider by MediFind in the treatment of Hemosiderosis. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Febrile Neutropenia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Keng is currently accepting new patients.
University Of Virginia Physicians Group
Ali Mahjoub is an Oncologist and a Hematologist in Fishersville, Virginia. Dr. Mahjoub and is rated as an Experienced provider by MediFind in the treatment of Hemosiderosis. His top areas of expertise are Anemia, Thrombocytopenia, Colorectal Cancer, and Angiosarcoma. Dr. Mahjoub is currently accepting new patients.
Terrence Reidy is a Palliative Medicine specialist and a Hematologist in Kearneysville, West Virginia. Dr. Reidy has been practicing medicine for over 47 years and is rated as an Experienced provider by MediFind in the treatment of Hemosiderosis. His top areas of expertise are Familial Prostate Cancer, End-Stage Renal Disease (ESRD), Polycythemia Vera, Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration.
Summary: Patients with hemochromatosis or Thalassemia develop progressive tissue and organs damages secondary to iron overload. Iron overload can result both from transfusional hemosiderosis and excess gastrointestinal iron absorption. Iron deposition in the heart, liver, and multiple endocrine glands results in severe damage to these organs, with variable degrees of endocrine and organ failure. Although p...
Summary: The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center